Atıf Formatları
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

G. D'Haens Et Al. , "Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis," NEW ENGLAND JOURNAL OF MEDICINE , vol.388, no.26, pp.2444-2455, 2023

D'Haens, G. Et Al. 2023. Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis. NEW ENGLAND JOURNAL OF MEDICINE , vol.388, no.26 , 2444-2455.

D'Haens, G., Dubinsky, M., Kobayashi, T., Irving, P. M., Howaldt, S., Pokrotnieks, J., ... Krueger, K.(2023). Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis. NEW ENGLAND JOURNAL OF MEDICINE , vol.388, no.26, 2444-2455.

D'Haens, Geert Et Al. "Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis," NEW ENGLAND JOURNAL OF MEDICINE , vol.388, no.26, 2444-2455, 2023

D'Haens, Geert Et Al. "Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis." NEW ENGLAND JOURNAL OF MEDICINE , vol.388, no.26, pp.2444-2455, 2023

D'Haens, G. Et Al. (2023) . "Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis." NEW ENGLAND JOURNAL OF MEDICINE , vol.388, no.26, pp.2444-2455.

@article{article, author={Geert D'Haens Et Al. }, title={Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis}, journal={NEW ENGLAND JOURNAL OF MEDICINE}, year=2023, pages={2444-2455} }